Skip Navigation
Menu
Editorials |1 May 2001

Mitochondrial DNA Mutations and Diabetes: Another Step toward Individualized Medicine

Nathan Fischel-Ghodsian, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • Dr. Fischel-Ghodsian: Cedars-Sinai Medical Center; Los Angeles, CA 90048

    Acknowledgment: The author thanks Drs. Leslie Raffel, Ricardo Perfetti, and Jerome Rotter for their comments on the editorial.

    Grant Support: By the National Institutes of Health/National Institute on Deafness and Other Communication Disorders (RO1DC01402 and RO1DC04092).

    Requests for Single Reprints: Nathan Fischel-Ghodsian, MD, Department of Pediatrics, Suite 1165WT, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048.

×
FULL TEXT
Twenty years ago, the mitochondrial chromosome was completely sequenced and the functions of all its genes were identified (1). Those genes code for 13 polypeptides, which are part of the more than 60 polypeptides that form the oxidative phosphorylation and adenosine triphosphate synthetase protein complexes in the inner membrane of the mitochondria. In addition, the mitochondrial chromosome codes for two ribosomal RNAs and 22 transfer RNAs, which participate in the translation of the 13 polypeptides on the mitochondrial ribosomes. Each cell contains hundreds of these chromosomes, and they are transmitted only through the ovum, leading to a maternal inheritance pattern. Inherited and acquired mutations in the mitochondrial chromosome have been implicated in a wide range of human diseases, including neuromuscular disorders, cardiomyopathies, skin lesions, aplastic anemia, Parkinson disease, and aging in general.
In 1992, three groups described several large families with a maternal inheritance pattern of diabetes, sensorineural deafness, or both, as well as a mitochondrial mutation (2-4). This should not have been a great surprise, since family and epidemiologic studies have shown repeatedly that patients with type 2 diabetes mellitus are more likely to have affected mothers than affected fathers and that the disease can be transmitted through several maternal generations (5-7). Apart from mitochondrial DNA mutations, this excess maternal transmission could also result from a maternal diabetic environment in utero that has a metabolic “teratogenic” effect on the fetus, or from the effect of imprinted genes that have a role only when transmitted through the...
FULL TEXT
PDF
Not Available
Citations
Citation

Fischel-Ghodsian N. Mitochondrial DNA Mutations and Diabetes: Another Step toward Individualized Medicine. Ann Intern Med. 2001;134:777–779. doi: https://doi.org/10.7326/0003-4819-134-9_Part_1-200105010-00014

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2001;134(9_Part_1):777-779.

DOI: 10.7326/0003-4819-134-9_Part_1-200105010-00014

©
2001 American College of Physicians
5 Citations

Related Articles
Several simple rules predicted complications in high-risk patients with diabetes
Annals of Internal Medicine; 136 (3): 117
New Modes of Insulin Administration: Do They Have a Role in Clinical Diabetes?
Annals of Internal Medicine; 105 (1): 126-129
Diabetes and the Endocrine Pancreas: A Biochemical Approach.
Annals of Internal Medicine; 101 (2): 291
Complications of Diabetes.
Annals of Internal Medicine; 99 (2): 827-828
View MoreView Less

Journal Club
Protocol-based nurse management of type 2 diabetes did not differ from usual GP care for HbA1c levels
Annals of Internal Medicine; 155 (6): JC3-7
View MoreView Less

Related Point of Care
Hearing Loss
Annals of Internal Medicine; 158 (7): ITC4-1
View MoreView Less

Related Topics
Cardiology
Coronary Risk Factors
Diabetes
Endocrine and Metabolism

Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.

PubMed Articles
Complications of Isolated Fungal Sphenoiditis: Patient Clinical Characteristics.
ORL J Otorhinolaryngol Relat Spec 2019.
Perilla oil regulates intestinal microbiota and alleviates insulin resistance through the PI3K/AKT signaling pathway in type-2 diabetic KKAy mice.
Food Chem Toxicol 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×